Z3 Capital Partners, LLC

Position in TRVI — Trevi Therapeutics, Inc.

CIK 2127787 RICHMOND, VA

Position in TRVI

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$732,012

+$260,181 QoQ

Shares Held

39,250

-0.8% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#121

of 216 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Z3 Capital Partners, LLC holds $2,076,262 across 4 Biotechnology names. TRVI ranks #1 (35.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TRVI	Trevi Therapeutics, Inc. This page	39,250	$732,012
2	ATAI	AtaiBeckley Inc.	92,525	$487,606
3	CRSP	CRISPR Therapeutics AG	8,000	$436,320
4	DYN	Dyne Therapeutics, Inc.	18,925	$420,324

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$732,012	39,250	-0.8%	Shares	Sole	2026-07-28
2026-03-31	$471,831	39,550	+0.3%	Shares	Sole	2026-05-07
2025-12-31	$493,914	39,450	—	Shares	Sole	2026-05-07
No filing history on record for this holder in this stock.